Arkolith/Insider Trading/ALT/Form 4

Gill John

DirectorAltimmune, Inc. (ALT) · full profile →Form 4 · filed Dec 23, 2025
Net Buying
Open-Market Buys
$51K
Open-Market Sells
$0
Net Open-Market Flow
$51K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 23, 2025Buy(P)13K$4.10$51K13K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001409939-25-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML